IBRX β€” IMMUNITYBIO INC

Ownership history in TWO SIGMA SECURITIES, LLC  Β·  6 quarters on record

This page tracks every 13F SEC filing in which TWO SIGMA SECURITIES, LLC reported a position in IMMUNITYBIO INC (IBRX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price β€” sourced directly from SEC EDGAR 13F filings.

πŸ” Peak position
0.01% (2025 Q3)
πŸ“Š Avg. % of fund
0.0%
πŸ“… First filed
2022 Q1
πŸ“… Last filed
2025 Q3
⏱ Quarters held
6

Position Intelligence

TWO SIGMA SECURITIES, LLC Γ— IBRX AI Analytics

πŸ“ˆ TWO SIGMA SECURITIES, LLC outperformed the S&P 500 by +78.3% annually on this IBRX position. Timing score: 60% (3/5 decisions correct). Average cost basis: $4.09. Maximum drawdown during holding period: –69.9%.

πŸ“ˆ Position Alpha vs SPY
+78.3%
annualised excess return

πŸ”₯ Exceptional β€” beat the S&P 500 by 78.3% per year on this position.
4 quarters analyzed

⏱️ Timing Score
60%

βœ… Decent timing β€” more right than wrong on entries and exits.
3 of 5 add/trim decisions correct

πŸ’° Entry Quality
$4.09
-39.9% vs current ($2.46)

Best entry: $1.69 (2023 Q3)  Β·  Worst: $5.61 (2022 Q1)

πŸ›‘οΈ Drawdown Resilience
–69.9%
max drawdown while held

πŸ’ͺ Held through 1 major drawdown (>20%). Strong conviction under pressure.

πŸ’ͺ Fund Conviction
67%
buy-side decisions

4 adds Β· 2 trims. Bought during 2 of 4 down-price quarters. πŸ“ˆ More buys than sells across the holding period.

πŸ“‘ Position Trajectory
β†’ Stable
last 4–5 quarters trend

βš–οΈ Portfolio weight has remained relatively stable β€” conviction maintained.
Currently 0.01% of portfolio

⚠ Based on quarterly 13F SEC filings and end-of-quarter closing prices. Timing score = accuracy of add/trim decisions vs next-quarter price direction. Alpha = mean quarterly excess return Γ— 4 (annualised). Not investment advice.

% of Fund (quarterly)    IBRX price (monthly, adj. close)
πŸ“‹ Quarterly Holdings History 6 quarters  β–Ύ
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 ADDED 22,860 +10,538 +85.5% 0.01% $56K $2.46
2025 Q2 REDUCED 12,322 -31,282 -71.7% 0.00% $33K $2.64
2023 Q4 ADDED 43,604 +9,624 +28.3% 0.00% $219K $5.02
2023 Q3 ADDED 33,980 +22,302 +191.0% 0.00% $57K $1.69
2023 Q1 REDUCED 11,678 -28,824 -71.2% 0.00% $21K $1.82
2022 Q1 INITIATED 40,502 β€” β€” 0.01% $227K $5.61

🏒 Other funds also holding IBRX

As of 2025 Q4 β€” sorted by position size

Kercheville Advisors, LLC 3Y 1.12% Winning Points Advisors, LLC 3Y 0.54% TANG CAPITAL MANAGEMENT LLC 3Y 7Y 0.23% Accurate Wealth Management, LLC 3Y 0.17% Virtus Investment Advisers, LLC 3Y 7Y 0.16% Clearwater Capital Advisors, LLC 3Y 7Y 0.14% SHEETS SMITH WEALTH MANAGEMENT 3Y 7Y 0.14% AlphaCore Capital LLC 3Y 0.13% ALLEN HOLDING INC /NY 3Y 7Y 0.13% COLLECTIVE FAMILY OFFICE LLC 3Y 0.07%
← Back to TWO SIGMA SECURITIES, LLC Holdings